Hedge Funds Have Mixed Feelings about These Surging Stocks

Then there’s is Vascular Biogenics Ltd (NASDAQ:VBLT), which has advanced by almost 19% in the intraday trading on Monday on a volume of 2.56 million shares, versus an average of just 134,300 shares. The increase extended the stock’s gains in the last couple of days, which reached over 50% in the last four days. Investors are looking forward to Vascular Biogenics Ltd (NASDAQ:VBLT)’s presenting Phase 2 Data on VB-111, an anti-angiogenic agent for cancer therapy, at the European Cancer Conference that starts at the end of the week. Earlier today, JMP Securities upgraded the stock to ‘Outperform’ from ‘Market Perform’, which fueled today’s appreciation. However, due to Vascular Biogenics Ltd (NASDAQ:VBLT)’s small size, it’s not very popular among smart money investors and none of the funds from our database own shares of the company.

Finally, Starwood Waypoint Residential Trust (NYSE:SWAY)‘s stock appreciated by more than 12% on Monday, after the announcement that the firm will acquire another owner of single-family properties, Colony American Homes in an all-stock deal worth around $1.50 billion. Even though, Starwood Waypoint Residential Trust (NYSE:SWAY) is not very popular among the funds from our database, with only 17 reporting stakes in the last round of 13F filings, they are very bullish on the company, amassing almost 33% of its outstanding stock, holding stakes worth $269.34 million. However, these figures declined during the second quarter from 19 funds that held $392.05 million worth of Starwood Waypoint’s stock at the end of March. More specifically, Emanuel J. Friedman’s EJF Capital is the largest shareholder of the trust in our database, holding 3.62 million shares as of the end of June, followed closely by John Khoury’s Long Pond Capital, which disclosed 3.05 million shares in its latest 13F. By a wide margin, Ken Griffin‘s Citadel Investment Group, which owns 1.41 million shares of Starwood Waypoint Residential Trust (NYSE:SWAY), ranked on the third spot.

Disclosure: none